Fed Circuit refuses Amgen unit appeal in win for Sanofi

The US Court of Appeals for the Federal Circuit has dismissed Immunex’s appeal against a decision invalidating its patent on treating inflammatory disorders.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Cozen O'Connor snaps up Kilpatrick Townsend duo

28 October 2020 Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.

Americas

Kilpatrick Townsend hires litigation team from DLA Piper

19 October 2020 Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.

Big Pharma

Sanofi and GSK launch coronavirus vaccine collaboration

14 April 2020 Sanofi and GlaxoSmithKline are pooling resources to create a vaccine for COVID-19, in what they call an “unprecedented” collaboration between the two pharma companies.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Fed Circuit refuses Amgen unit appeal in win for Sanofi

More on this story

Editor's picks

Editor's picks

More features